Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

Foreign Investment Shows Mixed Trends as Inflows & Outflows Balance

KAPCO reports significant profit decline in FY25

Millat Tractors (PSX: MTL) reports 40% drop in annual profit

Name	Price/Vol	%Chg/NChg
KSE100	155,384.51 274.67M	0.61% 944.82
ALLSHR	95,133.57 856.28M	0.49% 465.41
KSE30	47,466.99 137.10M	0.74% 347.09
KMI30	227,645.22 99.71M	0.67% 1519.50
KMIALLSHR	63,888.06 353.11M	0.50% 319.01
BKTi	41,761.78 72.20M	0.33% 138.95
OGTi	31,619.14 7.57M	0.41% 130.35

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	115,220.00	117,240.00 114,940.00	-2045.00 -1.74%
BRENT CRUDE	67.14	67.52 66.78	0.15 0.22%
RICHARDS BAY COAL MONTHLY	84.00	0.00 0.00	-1.20 -1.41%
ROTTERDAM COAL MONTHLY	93.00	0.00 0.00	0.05 0.05%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	62.90	63.24 62.52	0.21 0.34%
SUGAR #11 WORLD	15.90	15.98 15.80	0.11 0.70%